Bextra - Valdecoxib - Dosage - Side Effects - Interactions - Warnings
Bextra (valdecoxib) drug information, dosage, side effects, drug interactions, and warnings. Bextra, generic drug name valdecoxib, is/was a COX-2 selective inhibitor used to treat the inflammation and pain arthritis. Bextra is now discontinued. In April 2005, the maker of Bextra voluntarily withdrew the drug from the market.
- A - Z: Arthritis Drugs
- A - Z: Drug Costs
- A - Z: NSAIDs
- COX-2 Selective Inhibitors
- Inflammation
- Joint Pain
- Pain Relief
FDA Announces Changes For All NSAIDS; Bextra Withdrawn From Market
Following scrutiny of the class of arthritis drugs known as NSAIDS and COX-2 inhibitors, the FDA has taken action.
Q & A: FDA Actions On COX-2 Inhibitors & NSAIDs
On April 7, 2005, FDA announces planned regulatory actions for Bextra, Celebrex, and the non-selective prescription and over-the-counter (OTC) non-steroidal anti-inflammatory drugs (NSAIDs).
Bextra Withdrawal - What Should You Do If You Were Taking Bextra?
You can be reimbursed for unused Bextra tablets.
Patient Education: Bextra / Valdecoxib Tablets
Patient education for Bextra / valdecoxib tablets. This drug is discontinued in the United States. Patients taking Valdecoxib should contact their prescriber regarding discontinuation and alternative therapies.
Bextra History: How To Take Bextra For Arthritis
Bextra, like Celebrex and Vioxx, is a COX-2 specific inhibitor prescribed for the relief of pain, inflammation, and stiffness associated with osteoarthritis and rheumatoid arthritis. What should you know if you take Bextra?
11/08/2004 Bextra History: Pfizer Calls Bextra Study Unsubstantiated
11/08/2004, Pfizer called a new study about Bextra which cites an increased heart risk, reported at an American Heart Association meeting and in the New York Times, "unsubstantiated".
11/13/2002 Bextra History: FDA Issues Warning About Bextra
11/13/2002, The FDA issued warnings and product label changes for the drug Bextra (valdecoxib), based on postmarketing adverse reports.
11/19/2001 Bextra History: FDA Approves Bextra (Valdecoxib)
11/19/2001, the FDA approved Bextra (valdecoxib) for the treatment of signs and symptoms of osteoarthritis and adult rheumatoid arthritis, and the pain associated with menstrual cramping.
03/24/2001 Bextra History: FDA Asked To Approve Valdecoxib
On March 23, 2001, it was announced that Pharmacia has submitted a new drug application to the FDA (U.S. Food and Drug Administration) for approval of Valdecoxib, a second generation version of Celebrex.
